Fresenius Medical Care AG (FME) Form 6-K Summary

Filing Date: November 4, 2025

This Form 6-K furnishes the Company’s third quarter 2025 results (period ending Sept 30, 2025) via attached Press Release (Exhibit 99.1) and financial overview (Exhibit 99.2).

• Investor Focus: Actual financial performance metrics (revenue, earnings) are detailed in the attached exhibits.
• Key Metrics Highlighted: The filing emphasizes the use of several non-GAAP measures to supplement IFRS results:
  • EBITDA
  • Free Cash Flow (FCF)
  • Net Leverage Ratio (Net